161 related articles for article (PubMed ID: 10919162)
1. [Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease].
Zöphel K; Wunderlich G; Koch R; Franke WG
Nuklearmedizin; 2000; 39(4):113-20. PubMed ID: 10919162
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
Hermsen D; Liu C; Domberg J; Graeber C; Feldkamp J; Duan Y; Xu K; Liu C; Mao X; Scherbaum WA; Schott M
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S59-63. PubMed ID: 18777457
[TBL] [Abstract][Full Text] [Related]
4. [Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases].
Meller J; Schreivogel I; Bergmann A; Morgenthaler N; Hüfner M; Becker W
Nuklearmedizin; 2000; 39(1):14-8. PubMed ID: 10726252
[TBL] [Abstract][Full Text] [Related]
5. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M
Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
[TBL] [Abstract][Full Text] [Related]
6. On specificity of 2nd generation TSH receptor autoantibody measurements.
Zöphel K; Grüning T; Roggenbuck D; Wunderlich G; Kotzerke J
Clin Lab; 2008; 54(7-8):243-9. PubMed ID: 18942492
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders.
Cardia MS; Lima N; Knobel M; Medeiros-Neto G
Thyroid; 2004 Apr; 14(4):295-300. PubMed ID: 15142363
[TBL] [Abstract][Full Text] [Related]
8. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
9. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
[TBL] [Abstract][Full Text] [Related]
11. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
[TBL] [Abstract][Full Text] [Related]
12. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
Schott M; Feldkamp J; Bathan C; Fritzen R; Scherbaum WA; Seissler J
Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
[TBL] [Abstract][Full Text] [Related]
13. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
[TBL] [Abstract][Full Text] [Related]
14. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
15. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
16. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
17. Are porcine and human TSH receptor antibody measurements comparable?
Zöphel K; von Landenberg P; Roggenbuck D; Wunderlich G; Kotzerke J; Lackner KJ
Clin Lab; 2008; 54(1-2):1-8. PubMed ID: 18510037
[TBL] [Abstract][Full Text] [Related]
18. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
[TBL] [Abstract][Full Text] [Related]
19. Clinical review about TRAb assay's history.
Zöphel K; Roggenbuck D; Schott M
Autoimmun Rev; 2010 Aug; 9(10):695-700. PubMed ID: 20594972
[TBL] [Abstract][Full Text] [Related]
20. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.
Costagliola S; Morgenthaler NG; Hoermann R; Badenhoop K; Struck J; Freitag D; Poertl S; Weglöhner W; Hollidt JM; Quadbeck B; Dumont JE; Schumm-Draeger PM; Bergmann A; Mann K; Vassart G; Usadel KH
J Clin Endocrinol Metab; 1999 Jan; 84(1):90-7. PubMed ID: 9920067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
